Articles > Popular publications > PR Newswire press releases > April-June 2004 > Wednesday, April 14

Article: VaxGen Reports Positive Results of Animal Efficacy Studies of Smallpox Vaccine Candidate.

Article from:
PR Newswire
Article date:
April 14, 2004
Copyright

VaxGen, Inc. today announced top-line results from two animal studies of the effectiveness of its attenuated smallpox vaccine candidate, LC16m8. Both studies, which were conducted in mice and rabbits, respectively, demonstrated that a single dose of LC16m8 was as effective as the currently licensed vaccine, DryVax, in protecting against a lethal poxvirus challenge. LC16m8 is a live attenuated vaccinia vaccine and has been licensed for use in humans in Japan since 1980.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )

"These are the first animal efficacy studies to be reported which directly compare the effectiveness of LC16m8 and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: The National Institute of Allergy and Infectious ...
Business Wire;  August 18, 1998 ;     700+ words ... ... Aug. 18, 1998-- VaxGen Inc., the developer of the ... National Institute of Allergy and Infectious Diseases (NIAID), an agency within ... Institutes of Health, will join VaxGen in collaborative research ... that currently called for in VaxGen's Phase III trial plans ...

Article: VaxGen Selected by U.S. Government to Develop New Anthrax ...
PR Newswire;  October 3, 2002 ;     700+ words ... ... Institute of Infectious Diseases (USAMRIID ... positive, VaxGen will be eligible ... treatment of human infectious diseases," said VaxGen Chief Executive ... Allergy and Infectious Diseases, National ... 25494. About VaxGen VaxGen is ...

Article: VaxGen and Britain's Health Protection Agency Sign ...
PR Newswire;  September 3, 2003 ;     700+ words ... ... agreement between VaxGen and the U.S ... Research Institute of Infectious Diseases (USAMRIID) regarding ... intellectual property. VaxGen is developing the ... Institute of Allergy and Infectious Diseases (NIAID). VaxGen selected HPA as ...

Article: Nasdaq to Delist VaxGen's Stock on Aug. 9; Company Expects ...
PR Newswire;  August 6, 2004 ;     700+ words ... ... previously announced, VaxGen is applying a revised ... Institute of Allergy and Infectious Diseases (NIAID). The change in policy is driven by VaxGen's desire to ensure ... Brisbane, Calif., VaxGen is a biopharmaceutical ... treatment of human infectious diseases. NOTE: This press ...

Article: Head of VaxGen's Manufacturing Operations Receives ...
PR Newswire;  October 11, 2004 ;     700+ words ... ... CEO of Celltrion. VaxGen is preparing to manufacture ... Institute of Allergy and Infectious Diseases (NIAID) at its facility ... About VaxGen, Inc. VaxGen, Inc. is a biopharmaceutical ... treatment of human infectious diseases. Based in Brisbane ... anthrax and smallpox. ...

Article: VAXGEN WINS $878M BIOSHIELD CONTRACT FOR ANTHRAX VACCINE.
BIOWORLD Today;  November 8, 2004 ;     700+ words ... ... has had" in helping VaxGen develop rPA102, Gordon ... Institute of Allergy and Infectious Diseases funded the early development ... will be covered by VaxGen. The company expects ... recognition policy. VaxGen's vaccine is composed ... Research Institute of Infectious Diseases. The ...

Article: VaxGen to Present Update at SG Cowen Conference; Company ...
PR Newswire;  March 13, 2003 ;     700+ words ... ... and-answer periods. About VaxGen VaxGen is focused on the commercial ... prevention and treatment of human infectious diseases and is currently developing vaccines ... and HIV/AIDS. Additionally, VaxGen is the largest shareholder of ...

Article: VaxGen Provides Update on Financial Reaudit; Company ...
PR Newswire;  December 14, 2004 ;     700+ words ... ... conformity with U.S. GAAP. About VaxGen VaxGen, Inc. is a biopharmaceutical ... prevention and treatment of human infectious diseases. For more information, please ... web site at: http://www.vaxgen.com/. NOTE: This press release ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives